Intratumoral injection of the experimental oncolytic adenovirus XVir-N-31 induced immune-related tumor cell death and increased lymphocyte infiltration, which was further enhanced with the addition of anti-PD1 treatment [88]. This evidence concerns the gene PDCD1 and neoplasm.